JPS60190786A - Saccharide derivative - Google Patents

Saccharide derivative

Info

Publication number
JPS60190786A
JPS60190786A JP4502784A JP4502784A JPS60190786A JP S60190786 A JPS60190786 A JP S60190786A JP 4502784 A JP4502784 A JP 4502784A JP 4502784 A JP4502784 A JP 4502784A JP S60190786 A JPS60190786 A JP S60190786A
Authority
JP
Japan
Prior art keywords
tetramethyl
glucose
elemental analysis
formula
measured value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4502784A
Other languages
Japanese (ja)
Inventor
Tsutomu Kagitani
勤 鍵谷
Motonobu Minagawa
源信 皆川
Yutaka Nakahara
豊 中原
Bunji Hirai
平井 文二
Riyouji Kimura
凌治 木村
Etsuo Hida
悦男 飛田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeka Corp
Original Assignee
Adeka Argus Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeka Argus Chemical Co Ltd filed Critical Adeka Argus Chemical Co Ltd
Priority to JP4502784A priority Critical patent/JPS60190786A/en
Publication of JPS60190786A publication Critical patent/JPS60190786A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:A compound shown by the formula I [S is residue after removal of n HO from saccharide or sugaralcohol; A is O, NH, or OCO; X is H, or oxyl; R1 and R2 are H, linked to form one group; m is 0, or 1; n is 1-10]. EXAMPLE:1-(2,2,6,6-Tetramethyl-4-piperidyl)glucose. USE:A photostabilizer for organic material, etc. PREPARATION:For example, 66wt% NaH-mineral spirit solution is added little by little to 2,2,6,6-tetramethyl-4-hydroxypiperidine in DMF under cooling with ice, they are stirred at room temperature for 1hr, and it is reacted with 1- chloro-1-deoxy-2,3,4-6-tetraacetyl glucose. After the reaction product is isolated, it is deacetylated, to give 1-(2,2,6,6,-tetramethyl- 4-piperidyl)glucose shown by the formula II.

Description

【発明の詳細な説明】 本発明は、新規なヒンダードアミン基を有する糖誘導体
、詳しくは、合成重合体等の有機利料用光安定剤又はそ
の中間体、或いは生体関連物質又はその中間体として有
用なヒンダードアミン基を有する糖誘導体に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a novel sugar derivative having a hindered amine group, specifically, a light stabilizer for use in organic materials such as synthetic polymers or an intermediate thereof, or a biologically related substance or an intermediate thereof. The present invention relates to a sugar derivative having a hindered amine group.

2.2.6.6−チトラアルキルビベリジン化合物2,
2.6.6−チトラアルキルビロリン又はピロリジン化
合物は、ポリオレフィン、ボリウレクン、スチレン系樹
脂等の合成重合体をはじめとする各種有機材料の光安定
剤として知られている。
2.2.6.6-thitraalkylbiveridine compound 2,
2.6.6-Titraalkylbiroline or pyrrolidine compounds are known as light stabilizers for various organic materials including synthetic polymers such as polyolefins, polyurequins, and styrenic resins.

例えば、特公昭46−426’18号公報にば2゜2.
6.6−テトラメチル−4−ピペリジルアルキルエーテ
ルが記載され、特公昭4B−3211号公報には2,2
,6.6−テトラメチル−4−アミノピペリジン類が記
載され、米国特許第4064102号明細書には2,2
.6.6−テトラメチル−4−ピペリジンカルボン酸エ
ステルが記載され、米国特許第4111901号明細書
には2.2,5.5−テトラメチルピロリンスはピロリ
ジンカルボン酸エステルが記載されている。
For example, in Japanese Patent Publication No. 46-426'18, 2゜2.
6,6-tetramethyl-4-piperidyl alkyl ether is described, and 2,2
, 6,6-tetramethyl-4-aminopiperidines are described, and US Pat. No. 4,064,102 describes 2,2
.. 6,6-tetramethyl-4-piperidinecarboxylic acid ester is described, and 2,2,5,5-tetramethylpyrorinse is described as pyrrolidinecarboxylic acid ester in US Pat. No. 4,111,901.

しかしながら、これらの公報に記載の化合物を有機材料
の光安定剤として用いた場合、配合時或いは使用時にそ
の効果が急速に失われζしまい、その結果、有ta材料
を長期に渡って安定化することができなかった。
However, when the compounds described in these publications are used as light stabilizers for organic materials, their effects are rapidly lost during compounding or use, and as a result, they do not stabilize the tatable materials for a long period of time. I couldn't.

本発明者等は、斯る現状に鑑み鋭意検削をilねた結果
、新規な特定のヒンダードアミン基を有する糖誘導体が
有機材料用光安定剤として極め°ζ優れていることを知
見した。
In view of the current situation, the present inventors conducted intensive research and found that a new sugar derivative having a specific hindered amine group is extremely excellent as a light stabilizer for organic materials.

本発明は、上記知見に基づきなされたもので、次の一般
式(1)で表される、ヒンダードアミン基を有する糖誘
導体を提供するものである。
The present invention was made based on the above findings, and provides a sugar derivative having a hindered amine group, represented by the following general formula (1).

〔式中、■は糖類又は糖アルコール類からn ll&I
のヒドロキシ基を除いた残基を示ず。Aは−0−11 −NH−又は−0C−を示す。Xは水素原子又はオキシ
ル(−0・)を示す。R1及びR2ば水素原子を示すか
又は共同して直接結合手を示す。mば0又は1を示す。
[In the formula, ■ is from sugar or sugar alcohol.
Residues other than the hydroxyl group are not shown. A represents -0-11 -NH- or -0C-. X represents a hydrogen atom or oxyl (-0.). R1 and R2 represent a hydrogen atom or jointly represent a direct bond. m indicates 0 or 1.

nは1〜10を示す。〕上記一般式(’ I )で表さ
れる本発明の糖誘導体は、有機材料用光安定剤又はその
中間体として、或いは医薬、農薬用の有効成分として又
はこれらの中間体として゛有用である。
n represents 1 to 10. ] The sugar derivative of the present invention represented by the above general formula (I) is useful as a light stabilizer for organic materials or an intermediate thereof, or as an active ingredient for pharmaceuticals or agricultural chemicals, or as an intermediate thereof. .

以下に本発明の糖誘導体について詳述する。The sugar derivative of the present invention will be explained in detail below.

前記一般式(1)で表される本発明の糖誘導体において
、■で示される糖類又は糖アルコール類の残基としては
、アラビノース、リボース、キシロース、フラジ1−−
ス、ガラクトース、グルコース、マンノース、ソルボー
ス、グルコヘプトース、ラクトース、マルトース、シュ
クロース、トレハロース、メレズイトース、ラフィノー
ス、スタチオーゼ、デキストリン、シクロデキストリン
、グリコーゲン等の糖類の残基、及びトレイノド、エリ
トリット、アラビット、リビノト、キシリット、ソルビ
ット、マンニント、イジツト、タリソト、ズルシット、
アリット等の糖アルコール類の残基があげられる。
In the sugar derivative of the present invention represented by the general formula (1), the sugar or sugar alcohol residue represented by (■) includes arabinose, ribose, xylose, fladi
Residues of sugars such as galactose, glucose, mannose, sorbose, glucoheptose, lactose, maltose, sucrose, trehalose, melezuitose, raffinose, stathiose, dextrin, cyclodextrin, glycogen, and treinod, erythritol, aravit, ribinot, xylit , sorbit, manninto, ijituto, talisoto, zurcit,
Examples include residues of sugar alcohols such as Alit.

前記一般式(1)で表される本発明の糖誘導体は、糖類
のエーテル化、アミン化或いはエステル化の方法として
通常用いられる方法により容易に製造することができる
The sugar derivative of the present invention represented by the general formula (1) can be easily produced by a method commonly used for etherification, amination, or esterification of sugars.

以下に、前記一般式(1)で表される本発明の糖誘導体
の製造を示す実施例をあげて本発明を更に詳しく説明す
るが、本発明はこれらの実施例によって制限されるもの
ではない。
The present invention will be explained in more detail below by giving Examples showing the production of the sugar derivative of the present invention represented by the general formula (1), but the present invention is not limited by these Examples. .

実施例1 2.2,6.6−テトラメチル−4−ヒ1〜1゛!キシ
ピペリジン3.14 gをジメチルホルムアミ1゛に溶
解させ、これに水冷下66%水素化す1す1“ツム−ミ
ネラルスピリット/8液0.9gを少・量づつ添加した
後室温で1時間攪拌した。これに、予め常法に従いペン
クアセチルグルコースと塩化アルミニウムとの反応によ
り合成した1−り1コC1−−−1−デオキシ−2,3
,4,6−テ1−ラアセチルグルコース6.96g、を
氷冷下に少量づつ添加した。次いでこれを室温で5時間
攪拌後、溶媒を留去し、水に溶解させ、クロロホルムで
抽出した。クロロホルム層を合わせ、乾燥後脱溶媒し淡
褐色液体を得た。該液体から、シリカゲルカラムを用い
、トルエン/酢酸エチルを展開溶媒として目的化合物を
テトラアセチル体として分取した。これを無水メタノー
ルに溶解させた後、28%ナトリウムメト嗜 キサイド−メタノール溶液で加水分解を行った。
Example 1 2.2,6.6-tetramethyl-4-hy 1-1゛! 3.14 g of xypiperidine was dissolved in 1" dimethylformamide, and to this was added 0.9 g of 66% hydrogenated 1-1" mineral spirit/8 solution in small portions under cooling with water, and the mixture was heated at room temperature for 1 hour. To this, 1-di-1-C1--1-deoxy-2,3, which had been synthesized in advance by reacting penquacetyl glucose and aluminum chloride according to a conventional method, was added.
, 6.96 g of 4,6-te1-laacetylglucose were added little by little under ice-cooling. After stirring this at room temperature for 5 hours, the solvent was distilled off, the solution was dissolved in water, and extracted with chloroform. The chloroform layers were combined, dried, and then the solvent was removed to obtain a pale brown liquid. From the liquid, the target compound was fractionated as a tetraacetyl compound using a silica gel column using toluene/ethyl acetate as a developing solvent. After dissolving this in anhydrous methanol, it was hydrolyzed with a 28% sodium methoxide-methanol solution.

然る後、脱溶媒後クロロホルムで抽出し、脱溶媒f&n
−へキサンで洗浄し、微黄色粉末の生成物(目的化合物
)を得た。
After that, after removing the solvent, extract with chloroform and remove the solvent f&n.
-Washing with hexane gave a slightly yellow powder product (target compound).

融点: 74〜76℃ 元素分析: CHN 測定値(%) 56.89 9.18 4.35計算値
(%) 56.41 9.15 4.39構造式: 実施例2 2.2.6.6−テトラメチル−4−−−ヒ(1:+キ
シピペリジンに代えて2.2,6.6−テ1−ラメチル
−4−ヒドロキシピペリジン=■−オキシル3、44 
gを用いた以外は実施例1と同様にし′ζ橙色結晶の生
成物を得た。その後、該生成物をトルエン/n−ヘキサ
ンより再結晶した。
Melting point: 74-76°C Elemental analysis: CHN Measured value (%) 56.89 9.18 4.35 Calculated value (%) 56.41 9.15 4.39 Structural formula: Example 2 2.2.6. 6-Tetramethyl-4--H(1:+2.2,6.6-Te1-ramethyl-4-hydroxypiperidine=■-oxyl instead of 3,44
A product in the form of orange crystals was obtained in the same manner as in Example 1 except that g was used. Thereafter, the product was recrystallized from toluene/n-hexane.

融点:67.5〜68.5℃ Uv: λ243 8−2410 元素分析: C,HN 測定値(%) 53.06 9.01 4.18計算値
(%) 53.88 8.44 4.19構造式: 糖類として1−クロロ−1−デオキシ−2,3゜4−ト
リアセチルリボース5.60 、gを用いた以外は実施
例2と同様にして橙色粉末の生成物を得た。
Melting point: 67.5-68.5℃ Uv: λ243 8-2410 Elemental analysis: C, HN Measured value (%) 53.06 9.01 4.18 Calculated value (%) 53.88 8.44 4.19 Structural formula: An orange powder product was obtained in the same manner as in Example 2, except that 5.60 g of 1-chloro-1-deoxy-2,3°4-triacetyl ribose was used as the saccharide.

融点:69.0〜70.0°C Uv: λ241 ε−2180 元素分析: HN 測定値(%) 53.99 9.00 .1.66計算
値(%) 55.25 ’8.61 4.60構造式: 1唐類として1−クロロへブタアセチルマルトース一t
rWi黄褐色粉末の生成物を得た。
Melting point: 69.0-70.0°C Uv: λ241 ε-2180 Elemental analysis: HN Measured value (%) 53.99 9.00. 1.66 Calculated value (%) 55.25 '8.61 4.60 Structural formula: 1-chlorohebutaacetylmaltose 1 t
The product was obtained as a rWi tan powder.

融点: 81.0〜81.5℃ 元素分析: C H N 測定値(%) 53.44 9.01 2.47計算値
(%) 52.38 8.16 、 2.91構造式: 糖類として1−クロロヘプタアセチルマルトース1 2
. 4 4 gを用いた以外は実施例2と同様にして橙
色結晶の生成物を得た。
Melting point: 81.0-81.5°C Elemental analysis: C H N Measured value (%) 53.44 9.01 2.47 Calculated value (%) 52.38 8.16, 2.91 Structural formula: As a saccharide 1-chloroheptaacetylmaltose 1 2
.. A product of orange crystals was obtained in the same manner as in Example 2 except that 44 g was used.

融点: 66、o〜68.0℃ Uv: λ245 8−1985 元素分析: HN 測定値(%)49.79 8.11 2.79計算値(
%) 50.50 7.71 2.82構造式: 実施例6 無水グルコース1.8gを乾燥ジメチルポルムアミドに
懸濁させ、水冷下2,2,6.6−−テI・ラメチル−
4−アミノピペリジン1.9gを少量づつ添加した後、
40〜50°Cに加温し、グルコースを完全に溶解させ
た。80°Cで2.5時間攪拌した後、減圧下に溶媒を
留去し、無色のシロップ状物を得た。アセ1−ンを加え
結晶を析出させた後、濾過、アセトン洗浄後乾燥し、白
色粉末の生成物を得た。
Melting point: 66, o~68.0°C Uv: λ245 8-1985 Elemental analysis: HN Measured value (%) 49.79 8.11 2.79 Calculated value (
%) 50.50 7.71 2.82 Structural formula: Example 6 1.8 g of anhydrous glucose was suspended in dry dimethylpolamide, and under water cooling, 2,2,6.6--teI-ramethyl-
After adding 1.9 g of 4-aminopiperidine little by little,
It was heated to 40-50°C to completely dissolve glucose. After stirring at 80°C for 2.5 hours, the solvent was distilled off under reduced pressure to obtain a colorless syrup. Acetone was added to precipitate crystals, which were then filtered, washed with acetone, and dried to obtain a white powder product.

融点: 4o、s〜44.5℃ IR: 1670cm’ (NHに基づく吸収)元素分
析: HN 測定値(%)54.95 9.08 B、85計算値(
%)56.5B 9.50 8.80構造式: %式% ベリジンに代えて4−アミノ−2,2,Ei、6−テト
ラメチルビベリジン−1−オキシル2.1gを用いた以
外は実施例6と同様にして橙色粉末の生成物を得た。
Melting point: 4o, s ~ 44.5°C IR: 1670 cm' (absorption based on NH) Elemental analysis: HN Measured value (%) 54.95 9.08 B, 85 Calculated value (
%) 56.5B 9.50 8.80 Structural formula: %Formula% Except for using 2.1 g of 4-amino-2,2,Ei, 6-tetramethylbiveridin-1-oxyl in place of veridine. An orange powder product was obtained in the same manner as in Example 6.

融点: 3B〜44℃ UV: λ243 ε−2320 元素分析: HN 測定値(%) 53.64 9.12 8.08計算値
(%)54.04 8.77 8.40構造式: 糖類としてリボースを用いた以外は実施例〔jと同様に
して白色粉末の生成物を得た。
Melting point: 3B to 44°C UV: λ243 ε-2320 Elemental analysis: HN Measured value (%) 53.64 9.12 8.08 Calculated value (%) 54.04 8.77 8.40 Structural formula: Ribose as sugar A white powder product was obtained in the same manner as in Example [j except that .

融点: 50〜53℃ 元素分析: HN 測定値(%) 57.98 10.37 9.33計算
値(%) 58.31 9.79 9.’71構造式: ffM頬としてリボースを用いた以外は実施例7と同様
にして橙色粉末の生成物を得た。
Melting point: 50-53°C Elemental analysis: HN Measured value (%) 57.98 10.37 9.33 Calculated value (%) 58.31 9.79 9. '71 structural formula: ffM An orange powder product was obtained in the same manner as in Example 7 except that ribose was used as the cheek.

融点: 47〜51℃ UV: λ23t ε= 2410 元累分元素 CHN 測定値(%) 55.76 9.38 9.17計算値
(%) 55.43 8.97 9.23構造式: 実施例10 糖類としてマルトースを用いた以外は実施例6と同様に
して白色粉末の生成物を得た。
Melting point: 47-51°C UV: λ23t ε= 2410 Elemental cumulative element CHN Measured value (%) 55.76 9.38 9.17 Calculated value (%) 55.43 8.97 9.23 Structural formula: Example 10 A white powder product was obtained in the same manner as in Example 6 except that maltose was used as the saccharide.

融点: 79〜81℃ 元素分析: HN 測定値(%) 53.00 8.91 5.80計算値
(%) 52.49 B、39 5.83構造式: #i類としてマルトースを用いた以外は実施例7と同様
にして橙色粉末の生成物を得た。
Melting point: 79-81°C Elemental analysis: HN Measured value (%) 53.00 8.91 5.80 Calculated value (%) 52.49 B, 39 5.83 Structural formula: Except for using maltose as #i group An orange powder product was obtained in the same manner as in Example 7.

融点: 73〜78℃ Uv: λ2斗1 ε−1980 元素分析: HN 測定値(%) 49.81 8.06 5.84計算値
(%) 50.90 ’7.93 5..65構造式: %式% メチルピペリジン−4−カルボン酸メチルエステル2.
4g及びリチウムアミド80mgをジメチルホルムアミ
ドに熔解し、l Q Qmm figの減圧下、90℃
で15時間攪拌した。ベンゼンを加え、析出した結晶を
濾過、水洗後乾燥して生成物をIr、7だ。
Melting point: 73-78°C Uv: λ2to1 ε-1980 Elemental analysis: HN Measured value (%) 49.81 8.06 5.84 Calculated value (%) 50.90 '7.93 5. .. 65 Structural formula: %Formula% Methylpiperidine-4-carboxylic acid methyl ester2.
4 g and 80 mg of lithium amide were dissolved in dimethylformamide and heated at 90°C under a reduced pressure of l Q Qmm fig.
The mixture was stirred for 15 hours. Benzene was added, and the precipitated crystals were filtered, washed with water, and dried to obtain the product Ir, 7.

融点= 62〜65℃ IR: 1720cm−1,3430cm−1元素分析
: C)I N 測定値(%) 56.05’ 8.19 3.93計算
値(%) 56.78 8.58 4.14実施例13 ジイソプロピリデン−D−グルコース1.86g及びピ
リジン]、 14 gをベンゼン20+n!に溶解し、
1−オキシル−2,2,6,6−−ケトラメナルり4−
ピペリジンカルボン酸クロライl’2.58gを滴下し
た。滴下後、60°Cで15時間攪拌し、析出した塩を
濾別後溶媒を留去した。残渣にエーテルを加え溶解後、
a塩酸20m1を加え、室温で2時間攪拌した。水層を
とり、重ソウ水で中和後、乾固した。酢酸エチルで抽出
後、エーテルで処理して黄褐色粉末の生成物を得た。
Melting point = 62-65°C IR: 1720 cm-1, 3430 cm-1 Elemental analysis: C) I N Measured value (%) 56.05' 8.19 3.93 Calculated value (%) 56.78 8.58 4. 14 Example 13 1.86 g of diisopropylidene-D-glucose and pyridine], 14 g of benzene 20+n! dissolved in
1-oxyl-2,2,6,6--ketramenal-4-
2.58 g of piperidine carboxylic acid chloride I' was added dropwise. After the dropwise addition, the mixture was stirred at 60°C for 15 hours, the precipitated salt was filtered off, and the solvent was distilled off. After adding ether to the residue and dissolving it,
a 20 ml of hydrochloric acid was added, and the mixture was stirred at room temperature for 2 hours. The aqueous layer was taken, neutralized with heavy sodium chloride water, and then dried. After extraction with ethyl acetate, treatment with ether gave the product as a tan powder.

融点: 93〜97℃ Uv: λ245 8=2130 元素分析: HN 測定値(%) 52.75 7.71 .3.78計算
値(%) 53.04 7.73 3.81実施例14 ジイソプロピリデン−D−グルコース2.Og、2.2
.5.5−テトラメチルピロリジン−3−カルボン酸メ
チルエステル2.2g及びリチウムアミド0.08 g
をキシレン中で、生成するメタノールを除去しながら加
熱攪拌した。水洗後、溶媒を留去し、残渣にジオキサン
10m1及び濃塩酸lOm+を加え、室温で2時間攪拌
した。水層を分離し、重ソウ水で中和復水を留去した後
、クロロボルムで抽出し、微黄色固体の生成物を得た。
Melting point: 93-97°C Uv: λ245 8=2130 Elemental analysis: HN Measured value (%) 52.75 7.71. 3.78 Calculated value (%) 53.04 7.73 3.81 Example 14 Diisopropylidene-D-glucose 2. Og, 2.2
.. 2.2 g of 5.5-tetramethylpyrrolidine-3-carboxylic acid methyl ester and 0.08 g of lithium amide
The mixture was heated and stirred in xylene while removing generated methanol. After washing with water, the solvent was distilled off, and 10 ml of dioxane and 10 ml of concentrated hydrochloric acid were added to the residue, followed by stirring at room temperature for 2 hours. The aqueous layer was separated, neutralized with sodium hydrogen aqueous solution, condensate was distilled off, and then extracted with chloroborum to obtain a slightly yellow solid product.

融点: 115〜118℃ IR: 1720cm(,3420cm−1元素分析: CI(N 測定値(%)53.378.o44.o。Melting point: 115-118℃ IR: 1720cm (,3420cm-1 Elemental analysis: CI(N Measured value (%) 53.378. o44. o.

計算値(%) 54.05 7.80 4.20実施例
15 2.2,6.6−テトラメチルビベリジン−4−カルポ
ン酸メチルエステルの代わりに2,2I5.5−テトラ
メチルピロリジン−3−一カルボン酸メチルエステル2
.2gを用いた以外は実施例12と同様にして微黄色固
体の生成物をjSiだ。
Calculated value (%) 54.05 7.80 4.20 Example 15 2,2I5.5-tetramethylpyrrolidine- instead of 2.2,6.6-tetramethylbiveridine-4-carboxylic acid methyl ester 3-monocarboxylic acid methyl ester 2
.. The procedure was repeated in the same manner as in Example 12, except that 2 g was used, and the slightly yellow solid product was jSi.

融点= 71〜74℃ IR: 1720cin−’、3−430 cm−’元
素分析: HN 測定値(%) 54.81 7.94 4.08計算値
(%) 55.53 8.33 4.31実施例16 1−オキシル−2,2,6,6−テトラメチル−り−ピ
ペリジンカルボン酸クロライドの代わりに1−オキジル
ー−2,2,5,5−テトラメチルビロリン−3−カル
ボン酸クロライド2.4gを用いた以外は実施例13と
同様にして黄褐色粉末の生成物を得た。
Melting point = 71-74°C IR: 1720 cin-', 3-430 cm-' Elemental analysis: HN Measured value (%) 54.81 7.94 4.08 Calculated value (%) 55.53 8.33 4.31 Example 16 1-Oxyl-2,2,5,5-tetramethylbiroline-3-carboxylic acid chloride 2 instead of 1-oxyl-2,2,6,6-tetramethyl-ri-piperidinecarboxylic acid chloride A yellowish brown powder product was obtained in the same manner as in Example 13, except that .4 g was used.

融点: 105〜107℃ I R: 1045cm−’ 、1720cm−瓢34
20cm−1UV’ 7i246 s −1900 元素分析: C’HN 測定値(%) 51.44 6.92 3.85計算値
(%) 51.72 6.90 4.02実施例17 シユクロース0.9’3g、ピリジン0.56 [り及
びジメチルボルムアミド20m1をとり、これに室温で
1−オキシル−2,2,5,5−テトラメーエールビロ
リンー3−カルボン酸クロライドI’、 21;のジメ
チルホルムアミド溶液を滴下し、室温で5時間攪拌した
。溶媒を減圧下に留去し、残渣をベンゼンで洗浄後、酢
酸エチルで抽出した。酢酸エチルを留去し、黄褐色半固
体の生成物を冑だ。
Melting point: 105-107°C IR: 1045cm-', 1720cm-Gourd 34
20cm-1UV' 7i246 s -1900 Elemental analysis: C'HN Measured value (%) 51.44 6.92 3.85 Calculated value (%) 51.72 6.90 4.02 Example 17 Sucrose 0.9' Take 3 g of pyridine, 0.56 ml of pyridine and 20 ml of dimethylbormamide, and add dimethyl of 1-oxyl-2,2,5,5-tetramer viroline-3-carboxylic acid chloride I', 21; A formamide solution was added dropwise, and the mixture was stirred at room temperature for 5 hours. The solvent was distilled off under reduced pressure, and the residue was washed with benzene and then extracted with ethyl acetate. The ethyl acetate was distilled off to remove the yellow-brown semisolid product.

U■: λ243 6=2560 元素分析: C!−I N 測定値(%) 52..39 6.79 3.711計
算値(%) 53.41 6.82 4.15実施例1
8 ソルビトール1.82g、ピリジン3.3.2g及びジ
メチルホルムアミド40m1をとり、これに室温で1−
オキシル−2,2,6,6−チトラメチルピペリジンー
4−カルボン酸クロライl” 7.87 gのジメチル
ホルムアミド溶液を滴下し、室温で5時間攪拌した。以
下実施例17と同様に処理し、黄褐色固体の生成物を得
た。
U■: λ243 6=2560 Elemental analysis: C! -IN Measured value (%) 52. .. 39 6.79 3.711 Calculated value (%) 53.41 6.82 4.15 Example 1
8 Take 1.82 g of sorbitol, 3.3.2 g of pyridine and 40 ml of dimethylformamide, and add 1-
A dimethylformamide solution of 7.87 g of oxyl-2,2,6,6-titramethylpiperidine-4-carboxylic acid chloride was added dropwise and stirred at room temperature for 5 hours. A tan solid product was obtained.

軟化点二 60〜75℃ U〜′: λ246 8−2360 元素分析: C1,N 測定値(%)、58.61 B、49 5.56計算値
(%) 59.34 8.52 5.77実施例17 シユクロース0.68g、ピリジン1.52g及びジメ
チルホルムア(ド20m1をとり、これGこ室温で1−
オキシル−2,2,5,5−テトラン(−ルビロリン−
3−カルボン酸クロライド3.89 gのジメチルホル
ムアミド溶液を滴下し、室温でl (1時間攪拌した。
Softening point 2 60~75℃ U~': λ246 8-2360 Elemental analysis: C1,N Measured value (%), 58.61 B, 49 5.56 Calculated value (%) 59.34 8.52 5.77 Example 17 Take 0.68 g of sucrose, 1.52 g of pyridine and 20 ml of dimethylforma, and add 1-
Oxyl-2,2,5,5-tetran(-ruvirorin-
A solution of 3.89 g of 3-carboxylic acid chloride in dimethylformamide was added dropwise, and the mixture was stirred at room temperature for 1 hour.

以下実施例17と同様に処理し、黄褐色固体の生成物を
得た。
Thereafter, the same treatment as in Example 17 was carried out to obtain a yellowish brown solid product.

融点= 8B〜95℃ U■: λ243 ε=3140 元素分析: CHN 測定値(%) 59.45 7n 6.311計算値(
%) 60.36 7.07 6.71次に、本発明の
t!i誘導体の効果を実験例に、J:、り具体的に説明
する。
Melting point = 8B~95℃ U■: λ243 ε=3140 Elemental analysis: CHN Measured value (%) 59.45 7n 6.311 Calculated value (
%) 60.36 7.07 6.71 Next, the t! of the present invention! The effect of the i derivative will be specifically explained using an experimental example.

実験例1 本実験例は本発明の糖誘導体の有機利料用光安定剤とし
ての効果を示すものである。
Experimental Example 1 This experimental example shows the effect of the sugar derivative of the present invention as a light stabilizer for organic use.

ポリプロピレン100重量部、ステアリル−β−3,5
−ジー第3ブチル−4−ヒト1コキシフェニルプロビオ
ネ−1−0,2重量部及び試料化合物(表−1参照)0
.3重量部を用い、プレス加工して厚さQ、3mmのシ
ートを作成した。このシートを用い高圧水銀灯により耐
光性試験を行った。その結果を次の表−1に示す。
100 parts by weight of polypropylene, stearyl-β-3,5
-G-tert-butyl-4-human-1koxyphenylprobione-1-0.2 parts by weight and sample compound (see Table 1) 0
.. Using 3 parts by weight, a sheet having a thickness Q of 3 mm was produced by press working. A light resistance test was conducted using this sheet using a high-pressure mercury lamp. The results are shown in Table 1 below.

表−11 実験例■ 本発明の糖誘導体の生体関連物質としての作用をみるた
めに、チミンの放射線照射における増感効果を測定した
Table 11 Experimental Example ■ In order to examine the action of the sugar derivative of the present invention as a biologically relevant substance, the sensitizing effect of thymine upon radiation irradiation was measured.

パイレックス試験管中に、チミン1ミリモル及び試料化
合物(表−2参照)0.5ミリ当量(No・とじて)を
含む生理食塩水5mlをとり、窒素カスを30分間吹き
込んだ後、100Krad (28K rad / h
 )のγ線を照射した。照射後、溶液を高速液体クロマ
トグラフィ(品性LC−3A)にて分析し、生成物を確
認した。その結果を次の表−2に示す。
In a Pyrex test tube, 5 ml of physiological saline containing 1 mmol of thymine and 0.5 meq. rad/h
) was irradiated with gamma rays. After irradiation, the solution was analyzed by high performance liquid chromatography (LC-3A) to confirm the product. The results are shown in Table 2 below.

尚、表中、■はチミンの減少量(ミリモル)を、■は5
.6−シヒトロー5.6−−シヒISロキシチミンの生
成M(ミリモル)を、■は5−ヒ10キシメチルウラシ
ルの生成量をそれぞれ示す。
In addition, in the table, ■ indicates the amount of decrease in thymine (mmol), and ■ indicates the amount of decrease in thymine (mmol).
.. 6-Sihitro 5.6-Sihi IS The production M (mmol) of Roxithymine is shown, and ■ indicates the production amount of 5-Hi10-oxymethyluracil.

表−2 従来、ガンの放射線治療においては、細胞への放射線照
射により、DNA自体が切断されるものと考えられてい
たが、近年、DNA中のチミンがヒドロキシ化されるこ
とによりその立体構造が崩れ機能しなくなるものと推定
されている。
Table 2 Conventionally, in cancer radiotherapy, it was thought that the DNA itself was cleaved by irradiating cells, but in recent years, hydroxylation of thymine in DNA has led to changes in its three-dimensional structure. It is estimated that it will collapse and cease to function.

チミンは、無酸素状態では放射線を照射しても容易には
ヒドロキシ化されないことが確認されており、ガン細胞
は血液から酸素の供給を殆ど受けないので無酸素状態で
あり、実際のガンの放射線治療においても、増感剤を投
与しなければガン細胞は破壊されないことからも、上記
推定は裏付けられている。
It has been confirmed that thymine is not easily hydroxylated even when irradiated with radiation in an anoxic state, and cancer cells receive almost no oxygen supply from the blood, so they are in an anoxic state, and radiation exposure in actual cancers is difficult. The above assumption is also supported by the fact that cancer cells are not destroyed in treatment unless a sensitizer is administered.

本発明の糖誘導体は、表−2に示した如く、チミンのヒ
ドロキシ化を著しく促進しており、ガンの治療への応用
が期待されるものである。
As shown in Table 2, the sugar derivative of the present invention significantly promotes hydroxylation of thymine, and is expected to be applied to the treatment of cancer.

特許出願人 アデカ・アーガス化学株式会社 第1頁の続き ■発明者木村 凌治渭 社 @発明者飛1)悦男渭 社 [和市白幡5丁目2番13号 アデカ・アーガス化学株
式会、内 :和市白幡5丁目2番13号 アデカ・アーガス化学株
式会丙
Patent applicant ADEKA ARGUS CHEMICAL CO., LTD. Continuation of page 1 ■ Inventor Ryoji Kimura @ Inventor Hi 1) Etsuo Yoshisha [5-2-13 Shirahata, Waichi Adeca Argus Chemical Co., Ltd., Waichi 5-2-13 Shirahata ADEKA ARGUS CHEMICAL CO., LTD.

Claims (1)

【特許請求の範囲】 次の一般式(I)で表される、ヒンダード°アミン基を
有する糖誘導体。 〔式中、■は糖類又は糖アルコール順からn +111
11のヒドロキシ基を除いた残基を示す。Aば一〇−1
1 −N H−又は−OC−を示す。Xは水素原子又はオキ
シル(−〇・)を示ず。R1及びR2は水素原子を示す
か又は共同して直接結合手を示す。バーはO又は1を示
す。nは1〜10を示す。〕
[Scope of Claims] A sugar derivative having a hindered amine group, represented by the following general formula (I). [In the formula, ■ is n + 111 in the order of sugars or sugar alcohols.
The residues of No. 11 with the hydroxy group removed are shown. Aba10-1
1 -NH- or -OC-. X does not represent a hydrogen atom or oxyl (-〇.). R1 and R2 represent a hydrogen atom or jointly represent a direct bond. Bars indicate O or 1. n represents 1 to 10. ]
JP4502784A 1984-03-09 1984-03-09 Saccharide derivative Pending JPS60190786A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4502784A JPS60190786A (en) 1984-03-09 1984-03-09 Saccharide derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4502784A JPS60190786A (en) 1984-03-09 1984-03-09 Saccharide derivative

Publications (1)

Publication Number Publication Date
JPS60190786A true JPS60190786A (en) 1985-09-28

Family

ID=12707845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4502784A Pending JPS60190786A (en) 1984-03-09 1984-03-09 Saccharide derivative

Country Status (1)

Country Link
JP (1) JPS60190786A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441088B1 (en) 1989-01-21 2002-08-27 Clariant Finance (Bvi) Limited Polyamide hindered amines
JP2005154133A (en) * 2003-11-28 2005-06-16 Mitsubishi Electric Corp Elevator control device
WO2017038552A1 (en) * 2015-09-04 2017-03-09 Dic株式会社 Stabilizer compound, liquid crystal composition, and display element
US10633590B2 (en) 2015-09-04 2020-04-28 Dic Corporation Liquid crystal composition and liquid crystal display device including the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARBOHYDRATE RESEARCH=1981 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441088B1 (en) 1989-01-21 2002-08-27 Clariant Finance (Bvi) Limited Polyamide hindered amines
JP2005154133A (en) * 2003-11-28 2005-06-16 Mitsubishi Electric Corp Elevator control device
WO2017038552A1 (en) * 2015-09-04 2017-03-09 Dic株式会社 Stabilizer compound, liquid crystal composition, and display element
JPWO2017038552A1 (en) * 2015-09-04 2017-09-21 Dic株式会社 Stabilizer compound, liquid crystal composition, and display element
US10329252B2 (en) 2015-09-04 2019-06-25 Dic Corporation Stabilizer compound, liquid crystal composition, and display element
US10633590B2 (en) 2015-09-04 2020-04-28 Dic Corporation Liquid crystal composition and liquid crystal display device including the same

Similar Documents

Publication Publication Date Title
EP3250581B1 (en) Alpha-d-galactoside inhibitors of galectins
US4169204A (en) Psoralens
EP3245216B1 (en) Novel galactoside inhibitor of galectins
JPS6259715B2 (en)
EP0901501B1 (en) Nucleoside derivatives with photo-unstable protective groups
JPS60190786A (en) Saccharide derivative
JPH05505797A (en) antiarrhythmic agent
DE2858078C2 (en) 2-chloroethylnitrosoureas, processes for their preparation and pharmaceutical preparations containing these compounds
DE3106815A1 (en) "CHEMICAL COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTIGENIC OR IMMUNADINE ORBANTS"
JPH04500968A (en) nucleoside derivatives
US4849512A (en) 3-acylamino-3-deoxyallose derivatives
JPH06508107A (en) New and improved solvent-free synthesis method of etheric substituted protected monosaccharides and their selective hydrolysis
SU961354A1 (en) 3-flucrine-2,3-didesoxyadenozin showing cytostatic activity
JPS6054960B2 (en) Anti-inflammatory septacidin analogs
US20210363098A1 (en) Diversity-oriented synthesis of n,n,o-trisubstituted hydroxylamines from alcohols and amines by n-o bond formation
US3751462A (en) Process for preparation of substituted fluoromethanesulfonanilides
PT79158B (en) NITROSOUREES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
JPS60169483A (en) Sugaralcohol ketal compound
JPH0259837B2 (en)
KR100631754B1 (en) N-alkyloxycarbonyl-5-fluorocytosine derivatives and preparation method thereof
KR100730768B1 (en) 5'-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-5'-carboxylic acid and its derivatives, and process for preparing thereof
KR810000483B1 (en) Process for preparing n-alkyl piperidine derivatives
JP4328323B2 (en) Ribofuranose derivatives
JPH0381285A (en) N6,n6-disubstituted-adenosine-3',5'-cyclic phosphoric acid or salt thereof and production thereof
WO1989010361A1 (en) Novel compound and medicine containing same